Vegan Food Market Size: Growth, Projections and Forecasts

When analysts refer to the global vegan food market, they are not measuring veganism itself. They are measuring a specific commercial segment: the market for manufactured plant-based products designed to replicate or replace animal-derived foods. This distinction matters, and understanding it is the right starting point for any serious analysis of market size, growth trajectories, and long-range forecasts.

1. What the Market Data Does Not Measure

A fully adequate vegan diet does not require products labelled as a plant-based substitutes. Lentils, chickpeas, black beans, tofu, tempeh, oats, quinoa, nuts, seeds, and an enormous variety of fruits and vegetables have formed the nutritional foundation of plant-based diets across cultures and centuries, long before the term ‘vegan food market’ existed as an analytical category. These whole and minimally processed foods supply the protein, fibre, iron, calcium, zinc, and complex carbohydrates that human physiology requires, and they do so without the manufacturing, packaging, or marketing infrastructure that commercial market research tracks.

To measure the true monetary scale of vegan food consumption globally would require accounting for every purchase of every product derived entirely from non-animal sources: from a bag of dried lentils bought at a market in Mumbai, to a jar of tahini in a Madrid supermarket, to a kilo of locally grown tomatoes in Nairobi. That figure is immeasurable, and in any case, the overwhelming majority of these products are not purchased because they are ‘vegan’. They are purchased because they are food.

What the existing market research infrastructure does measure, and what this article analyses, is a much narrower commercial category: products explicitly marketed and labelled as alternatives to animal-derived foods. Plant-based burgers, oat milk, vegan cheese, soy-based meat substitutes, pea protein powders. These are the products that market research firms track, that retailers classify in dedicated plant-based aisles, and that venture capital has funded at extraordinary scale. They are a real and commercially significant market. But they are not the same thing as the full dietary universe of vegan food.

This distinction is not a criticism of the research. It is a necessary interpretive frame. When a headline states that the vegan food market is worth €17 billion, it means: the global market for commercially manufactured and explicitly labelled plant-based substitute products is worth €17 billion. The full monetary value of all food consumption compatible with a vegan diet is orders of magnitude larger, and fundamentally unmeasurable.

2. The Role of Processed Substitutes

Having established what the data does not capture, it is equally important to be clear about why the segment it does capture matters.

Processed plant-based substitutes, meat analogues, dairy alternatives, plant-based ‘eggs’, serve a function that whole plant foods alone cannot easily serve for many consumers: they offer a low-friction transition. A person who has eaten beef burgers and dairy milk for thirty years faces a significant cognitive and culinary adjustment when considering a vegan diet. A plant-based burger that cooks, tastes, and functions like its animal-derived counterpart lowers that barrier considerably. The same is true for oat milk in coffee, plant-based mince in pasta sauce, or vegan cheese on pizza. These products meet consumers where their habits are, rather than requiring habits to change first.

This gateway function has measurable real-world significance. Research consistently finds that flexitarian consumers, those reducing rather than eliminating animal product consumption, account for the majority of plant-based product sales. They are not ideologically vegan; they are pragmatically reducing. Convenient, familiar-format substitutes are often what makes that reduction sustainable in practice.

The technological innovation embedded in these products also deserves recognition on its own terms. Achieving the fibrous texture of whole-muscle meat from pea protein isolates, the stretch of mozzarella from cashew fermentation, or the emulsification properties of egg from mung bean extract represents genuine scientific and culinary achievement. This innovation is commercially driven, but its downstream effects on reducing animal product consumption, if it succeeds at scale, carry real environmental and animal welfare implications that extend well beyond the commercial market.

The market data that follows is therefore worth reading with the interpretive context established above. It measures a commercially and culturally significant segment of the broader plant-based food transition, not the entirety of that transition, but an important and distinctly quantifiable dimension of it.

3. Current Market Valuations: What the Research Firms Report

Estimates for the global commercial plant-based substitute market in 2024-2025 vary substantially across sources, not because analysts fundamentally disagree about the underlying commercial reality, but because they define, scope, and measure that reality differently. Three variables account for most of the divergence: how narrowly or broadly each firm defines the product scope, whether foodservice revenues are included alongside retail, and how comprehensively emerging markets in Asia-Pacific and Latin America are covered.

Precedence Research estimates the market at approximately €17.09 billion (USD 20.18 billion) in 2024, focusing on packaged vegan food products across meat substitutes, dairy alternatives, and plant-based ‘eggs’, with North America as the largest contributor. Straits Research places the 2024 market higher at approximately €20.99 billion (USD 24.8 billion), reflecting broader category inclusion and stronger coverage of Asia-Pacific and Latin American markets. Grand View Research estimates €18.75 billion (USD 22.14 billion) for 2025, identifying vegan ‘meat’ and ‘seafood’ as the leading segment by revenue share. IMARC Group reports a more conservative figure of approximately €16.88 billion (USD 19.93 billion) for 2024. The resulting range, roughly €17 billion to €21 billion, represents a reasonable commercial research consensus band for plant-based substitute market in 2024.

The Good Food Institute (GFI) takes a different approach: rather than constructing modelled estimates, it commissions point-of-sale retail data from SPINS and Circana across a number of major markets. Based on this methodology, GFI estimates global plant-based retail sales at approximately €24.22 billion ($28.6 billion) in 2024.

Table 1: Market Estimates for the Commercial Plant-Based Substitute Market (2024-2025)

SourceBase Year Estimate (EUR)
Precedence Research€17.09B (2024)
Straits Research€20.99B (2024)
Grand View Research€18.75B (2025)
IMARC Group€16.88B (2024)
GFI (retail estimate)€24.22B (2024)

Sources: Precedence Research (2024); Straits Research (2024); Grand View Research (2025); IMARC Group (2024); Good Food Institute (2025). EUR values converted from USD at the 2025 ECB annual average rate of 1 EUR = 1.1306 USD.

4. Historical Growth Trajectory: 2017 to 2024

The commercial plant-based substitute market’s expansion over the past decade is most clearly understood through a global lens. GFI estimates that global plant-based retail sales in 2024 stood at roughly double the level recorded seven years prior. This trajectory was far from uniform: it unfolded through a boom, a correction, and a geographic divergence that now defines the market’s contemporary character.

The Boom Phase: 2019-2021

Across major markets, 2019 to 2021 represented a clear inflection point. In the United States, GFI’s SPINS-based tracking shows the plant-based retail market grew from approximately €3.30 billion (USD 3.9 billion) in 2017 toward a peak around €6.55 billion (USD 7.4 billion) in 2021, driven by high-profile product launches from Beyond Meat and Impossible Foods, expanded retail placement, rising media attention, and a pandemic-era sharpening of health consciousness among consumers. Venture capital flowed into the category at extraordinary pace, with 2021 representing peak investment, an environment GFI analysts subsequently attributed to an extended period of near-zero interest rates amplifying speculative enthusiasm for the sector.

Europe experienced a parallel expansion. GFI Europe’s analysis of NielsenIQ retail data across 13 European countries shows that plant-based food sales grew approximately 21% between 2020 and 2022, reaching €5.7 billion. Over the same period, plant-based ‘meat’ unit sales across the covered markets grew 19%, while conventional meat unit sales declined in several of the markets tracked over the same window. Plant-based ‘seafood’, though from a very small base, recorded particularly rapid unit sales growth between 2020 and 2022. In Asia-Pacific, soy-based products maintained deep cultural roots while next-generation analogues began appearing in urban retail, and several governments in the region articulated explicit support for alternative protein development.

The Correction: 2022–2023

From 2022 onwards, growth moderated, and in some markets reversed, as macroeconomic conditions shifted sharply. Elevated global inflation compressed household budgets and made the price premium carried by most engineered plant-based substitutes more acutely visible to consumers. In the United States, plant-based retail sales moderated in 2022 and declined in both 2023 and 2024. Unit sales of plant-based ‘meat’ declined significantly from their 2021-2022 peak, approximately 28% (between 2022 and 2024), depending on the dataset and product category examined, and overall U.S. plant-based retail stood at €6.86 billion (USD 8.1 billion) by 2024. That figure remains roughly double the 2017 level, but sits well below the trajectory that peak-enthusiasm forecasts had projected.

Europe’s correction was considerably more contained. Across six major European economies, Germany, France, Italy, Spain, the Netherlands, and the United Kingdom,  GFI Europe’s Circana-based analysis shows total plant-based retail sales grew 5.5% in 2023 to reach €5.4 billion, with volume sales also rising 3.5%. The UK and Netherlands recorded declines, attributed primarily to cost-of-living pressures, but Germany, France, Italy, and Spain all saw growth. The inflationary period also partially narrowed the relative price gap: across European markets tracked, conventional meat prices rose approximately 11% in 2022 while plant-based ‘meat’ prices increased just 1%, reducing the premium that had historically deterred price-sensitive consumers.

Divergence and Stabilisation: 2024

By 2024, a clear geographic divergence had emerged as the defining feature of the global market. GFI estimates global plant-based retail grew approximately 5% to €24.22 billion (USD 28.6 billion) a positive aggregate that conceals materially different regional trajectories. The United States continued to contract, with overall plant-based retail falling approximately 4% by value. European markets showed resilience and, in several countries, accelerating volume growth: France posted 8.8% value growth and Italy 7.6% versus 2023, while Germany recorded 7.1% volume growth, largely driven by private-label products.

5. Segment-Level Market Sizing

Within the commercial plant-based substitute market, plant-based dairy alternatives, milk, yogurt, cheese, cream, and ice cream, constitute the largest segment by revenue across most methodologies. Plant-based ‘meat’ and ‘seafood’ is the second-largest segment: Grand View Research³ identifies it as the leading segment by revenue share at roughly one-third of total market revenue of their 2025 market estimate; separately, GFI’s retail tracking estimates global plant-based ‘meat’ and ‘seafood’ sales at approximately €5.70 billion (USD 6.73 billion) in 2024, growing roughly 4% year-on-year. These two figures derive from different methodologies and scopes and are not directly comparable. Beyond the dominant dairy and meat segments, emerging categories such as protein powders, and fermentation-derived proteins are gaining commercial traction, though from a considerably smaller base. 

6. Investment Landscape

Venture capital and institutional investment flows offer a forward-looking dimension of market analysis that revenue figures alone cannot capture. In the commercial plant-based sector, 2024 investment data presents a considerably more sobering picture than aggregate retail sales growth might suggest.

According to GFI’s 2024 State of the Industry analysis⁵, plant-based food startups raised approximately €261.7 million (USD 309 million) in venture capital in 2024, a 64% decline from 2023 levels of approximately €723.2 million (USD 854 million), and a fraction of the peak volumes recorded during 2020-2022. Cultivated ‘meat’ attracted approximately €117.7 million (USD 139 million), a 40% decline and the sector’s lowest annual total since 2019. GFI notes that in the three years from 2022 to 2024, cultivated ‘meat’ cumulatively attracted less capital than it raised in 2021 alone.

The one notable exception was fermentation-derived proteins, where venture capital increased approximately 43% in 2024 relative to 2023, led by Meati’s €84.7 million (USD 100 million) Series C round. Fermentation also surpassed plant proteins in terms of public capital invested, reflecting growing government interest in diversifying protein supply chains as part of broader climate and food security commitments.

The investment contraction carries structural consequences. Without successful exits, through IPOs, acquisitions, or other liquidity events, investment in plant-based companies is unlikely to return to peak 2020-2022 levels in the near term, according to GFI’s analysis. This creates a consolidation dynamic: underfunded startups face pressure to merge, downsize, or exit, while established food conglomerates that have maintained plant-based portfolios are positioned to gain relative market share . The pace of product innovation and price reduction, two of the key variables underpinning optimistic long-range forecasts, could slow if the investment drought persists.

7. Growth Forecasts Through 2034: Projections and Consensus

Despite the investment headwinds of 2024, long-range forecasts from market research firms remain broadly bullish on the commercial plant-based substitute market. The commercial market research consensus, clusters around a projected CAGR range of approximately 9-11.5% for the period 2025-2034, with terminal market values ranging from approximately €35.65 billion (IMARC Group, by 2033) to €54.57 billion (Straits Research, by 2033). Outlier projections exist,  Market Research Future, for instance, projects a CAGR exceeding 16% through 2035, but these sit well outside the consensus and rely on notably aggressive assumptions.

Table 2: Long-Range Market Forecasts (2033-2034 Horizon)

Research FirmForecast Value (EUR)Target YearCAGR
Straits Research€54.57B (USD 64.47B)203311.2% (2025-2033)
Grand View Research€44.50B (USD 52.56B)203311.5% (2026-2033)
Precedence Research€46.91B (USD 55.42B)203410.63% (2025-2034)
IMARC Group€35.65B (USD 42.09B)20338.66% (2025-2033)

Sources: Straits Research (2024); Grand View Research (2025); Precedence Research (2024); IMARC Group (2024). EUR values converted from USD at the 2025 ECB annual average rate of 1 EUR = 1.1306 USD.

A pragmatic reading of these forecasts suggests the commercial plant-based substitute market is likely to reach somewhere in the range of €36-55 billion by 2033-2034, with the most internally consistent estimates clustering around the €44-47 billion mark. The wide forecast band reflects genuine uncertainty about the pace at which these products will enter mainstream consumer baskets, particularly in price-sensitive markets where the premium over conventional animal products remains large and where investment-driven innovation has slowed.

8. Structural Drivers Underpinning the Growth Forecasts

The forecast figures are grounded in several converging structural trends. Health consciousness, particularly awareness of plant-based diets’ links to reduced chronic disease risk, is expanding. Growing environmental awareness, driven by well-documented links between animal agriculture and greenhouse gas emissions, is influencing purchase decisions especially among younger demographics. Consumer motivations include animal welfare, ethical concerns, and the rise of flexitarianism.

On the supply side, continuous product innovation, improved taste and texture, and the expansion of private-label plant-based lines in mainstream retail, is lowering barriers to trial. Distribution dynamics include the growth of dedicated plant-based sections in supermarkets and the role of e-commerce in reaching consumers outside mainstream retail footprints. The high global prevalence of lactose intolerance, particularly across East and Southeast Asia, South Asia, and Latin America, also creates demand for dairy alternatives among consumers making a physiological rather than ideological choice, widening the addressable market beyond committed vegans and flexitarians.

9. Barriers to Growth: The Constraints on Forecasts

No assessment of growth projections is complete without acknowledging the structural constraints that could prevent forecasts from materialising at their projected rates.

Price premium: According to Statista data cited by Straits Research, plant-based meat alternatives carry an average price premium of approximately 82% over conventional counterparts, with plant-based ‘eggs’ commanding an even higher premium of approximately 112%. This structural price gap, driven by specialised ingredient costs, smaller production volumes, and limited economies of scale,  remains the most significant barrier to mainstream adoption, particularly in price-sensitive markets. Conventional animal products also benefit from substantial government subsidies in most major markets, creating a structural imbalance that plant-based producers cannot easily overcome through innovation alone.

Investment drought: The 64% contraction in venture capital investment in 2024 directly limits the innovation capacity of smaller plant-based companies. Without sustained funding, the product quality improvements and price reductions that underpin optimistic forecasts will proceed more slowly. GFI’s analysis anticipates that investment is unlikely to return to peak 2020-2022 levels without successful exits, meaning the commercial plant-based sector may face a period of consolidation rather than acceleration in the near term.

Additional constraints, include: ongoing taste and texture limitations in certain product categories, growing consumer scrutiny of ultra-processed foods, and a fragmented and contested regulatory environment across major markets.

Conclusion

The global commercial plant-based substitute market has grown substantially over the past decade, but not in a straight line. The boom of 2019-2021, the inflationary correction of 2022-2023, and the geographic divergence of 2024 illustrate a market shaped as much by external economic conditions as by underlying consumer demand. Despite those cycles, a broadly bullish consensus that has not materially softened in the face of recent headwinds.

The structural drivers supporting that outlook are real: rising health and environmental awareness, the growing role of flexitarians as the market’s primary growth engine, the expansion of private-label plant-based products in mainstream retail, and the physiological demand for dairy alternatives among the large share of the global population affected by lactose intolerance.

Against these, the barriers are equally concrete: price premiums over conventional animal products, a contraction in venture capital in 2024, ongoing product limitations in categories where taste and texture have not yet reached parity, and consumer scrutiny of ultra-processed foods.

Whether the sector reaches the upper or lower end of the forecast range will ultimately depend on the confluence of all these forces: the pace at which consumer demand matures, the ability of producers to close the price and quality gap, the flow of investment capital, and the degree to which external conditions: economic, regulatory, and political, work with or against the transition.

References and Further Reading

1. Precedence Research (2024). Vegan Food Market Size, Growth, Trends 2024-2034.

2. Straits Research (2024). Vegan Food Market Size, Share & Trends 2024-2033.

3. Grand View Research (2025). Vegan Food Market Size, Share & Trends Analysis.

4. IMARC Group (2024). Vegan Food Market Size, Share, Trends and Forecast 2025-2033.

5. Good Food Institute (2025). 2024 State of the Industry: Plant-Based Meat, Seafood, Eggs, Dairy, and Ingredients.

6. GFI & Plant Based Foods Association (2025). 2024 Plant-Based Foods State of the Marketplace Report (SPINS/Circana data).

7. GFI Europe (2025). European Plant-Based Sales Data 2022-2024 (Circana analysis).

8. GFI Europe (2023). Europe Plant-Based Foods Retail Market Report 2020-2022 (NielsenIQ analysis).

9. European Central Bank (2025). Euro foreign exchange reference rates – annual averages.